ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Stem Cell and Genetic Therapies for Hair Cell-Related Hearing Loss

by Sue Pondrom • June 1, 2007

  • Tweet
  • Email
Print-Friendly Version

SAN DIEGO-The remarkable new tools of the genomic generation have been used by researchers at the House Ear Institute in Los Angeles, Translational Genomics Research Institute in Phoenix, and the University of Antwerp, Belgium, to zero in on genes that cause presbycusis, or age-related hearing loss.

You Might Also Like

  • New Therapies for Hair Transplantation
  • Stem Cell-Based Organ Transplants Emerging as Alternative to Conventional Donations
  • Drug Trials for Hearing Loss, Tinnitus Therapies Show Promise
  • Otolaryngology Research Increasingly Supports Genetic Screening to Evaluate Pediatric Hearing Loss
Explore This Issue
June 2007
Rick A. Friedman, MD, PhD

Rick A. Friedman, MD, PhD

Rick A. Friedman, MD, PhD, of the House Ear Institute, described the scientists’ work at the Triological Society‘s Otology Forum April 26 at the Combined Otolaryngology Spring Meetings. He and his collaborators (not in attendance at COSM) studying the genetics of presbycusis included Dietrich Stephan, PhD, of Translational Genomics, Guy Van Camp, PhD, University of Antwerp, and the company Affymetrix.

While tempting the hundreds of COSM attendees with this exciting, sneak-peek look at the yet unpublished research, Dr. Friedman also explained the rationale behind genomic studies into complex traits where multiple pathways lead to common diseases such as hypertension, diabetes, and presbycusis.

His presentation was the lead talk in the research update. Additional presenters included Neil Segil, PhD, also from the House Ear Institute, who discussed the potential of hair cell regeneration with endogenous progenitor cells-specifically supporting cells; Allen Ryan, PhD, Professor of Otolaryngology at the University of California, San Diego (UCSD), who addressed the progress and challenges of stem cell therapy for the inner ear; and Bryan A. Liang, MD, PhD, JD, a medical ethics and legal expert based in San Diego, who reminded colleagues about liability, medical board sanctions, and the slime factor associated with judgment errors in today’s cutting-edge, genomic basic and clinical research.

Whole Genome Association Studies

Noting that his goal in organizing the forum was to convey the importance of this era of genomic medicine and potential stem cell therapies, Dr. Friedman based his remarks on his recent whole genome association studies. He said that since common diseases such as presbycusis result from common variations within the human genome, special tools are needed to detect the subtle differences that result in a variation of the expression of the gene, but not necessarily by its absence.

Allen Ryan, PhD

Allen Ryan, PhD

Key to the discovery of these subtle differences was the Affymetrix DNA microarrays, tiny silicon microchips with 500,000 bits of DNA information. The newest version of these microarrays was utilized by Dr. Friedman and his team as they searched for the gene or genes responsible for age-related hearing loss. The genes of more than 800 European subjects (with and without presbycusis) were subjected to the analysis of single nucleotide polymorphisms (SNPs) in an expensive ($1,000 per chip) study. The team has identified several markers at locations throughout the genome, all showing statistical significance and interplay to create the genetic risk for presbycusis.

Pages: 1 2 3 4 | Single Page

Filed Under: Otology/Neurotology Issue: June 2007

You Might Also Like:

  • New Therapies for Hair Transplantation
  • Stem Cell-Based Organ Transplants Emerging as Alternative to Conventional Donations
  • Drug Trials for Hearing Loss, Tinnitus Therapies Show Promise
  • Otolaryngology Research Increasingly Supports Genetic Screening to Evaluate Pediatric Hearing Loss

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Vertigo in the Elderly: What Does It Mean?
    • Non-Acidic Reflux Explains Lack of Response to H2 Blockers and PPIs
    • How 3D Printing Is Transforming the Pediatric Otolaryngology Field
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.